vClinic: Rosa Visits 2-3
The NLA is pleased to announce the new Virtual Patient Management Series (vClinicTM) program vClinic: Rosa - Visits 2 & 3. This new vClinic will address key knowledge and competency gaps for optimizing adherence to lipid-modifying therapies, in order to reduce the risk of morbidity and mortality from cardiovascular disease and related cardiometabolic conditions. The goal of this adherence vClinic is to provide learners with a practical framework to 1) improve patient adherence to lipid lowering therapies, including the diagnosis and treatment of statin intolerant patients; and 2) to overcome barriers to due statin intolerance, perceived risk for side effects, and/or treating existing side effects.
The NLA vClinic is an ideal environment to explore strategies to improve patient adherence to lipid therapy because the format replicates real-world patient encounters, enabling learners to assess and manage virtual patients, interact with peers and subject matter experts, and manage virtual patients across multiple visits and care settings.